Jiwoong Chun
Director/Board Member at Neuroptika, Inc.
Profile
Jiwoong Chun is currently a Director at KTB Network Co., Ltd., GenEdit, Inc., and Neuroptika, Inc. He previously worked as a Director at Bridge Biotherapeutics, Inc. in 2019.
Chun received his graduate degree from Seoul National University in 2007 and his undergraduate degree from Kyungsung University in 2005.
Jiwoong Chun active positions
| Companies | Position | Start |
|---|---|---|
KTB Network Co., Ltd. (Venture Capital)
 KTB Network Co., Ltd. (Venture Capital) Investment ManagersFinance KTB Network Co., Ltd. (Venture Capital) is a venture capital subsidiary of Daol Investment Co., Ltd. founded in 1981. KTB Network Co., Ltd. (Venture Capital) is headquartered in Seongnam, South Korea with offices in Shanghai, Palo Alto and Singapore. | Private Equity Investor | 2014-08-31 |
GenEdit, Inc.
 GenEdit, Inc. Pharmaceuticals: MajorHealth Technology GenEdit, Inc. develops gene therapies and gene editing-based therapeutics. Its proprietary nanoparticles applies for the development of CRISPR-based therapeutics and gene therapy products for a range of genetic diseases. The company was founded by Kunwoo Lee, Niren Murthy, and Hyo Min Park in 2016 and is headquartered in Berkeley, CA. | Director/Board Member | 2020-10-31 |
Neuroptika, Inc.
 Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Director/Board Member | 2018-12-31 |
Former positions of Jiwoong Chun
| Companies | Position | End |
|---|---|---|
| BRIDGE BIOTHERAPEUTICS, INC. | Director/Board Member | 2019-11-30 |
Training of Jiwoong Chun
| Seoul National University | Graduate Degree |
| Kyungsung University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BRIDGE BIOTHERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
KTB Network Co., Ltd. (Venture Capital)
KTB Network Co., Ltd. (Venture Capital) Investment ManagersFinance KTB Network Co., Ltd. (Venture Capital) is a venture capital subsidiary of Daol Investment Co., Ltd. founded in 1981. KTB Network Co., Ltd. (Venture Capital) is headquartered in Seongnam, South Korea with offices in Shanghai, Palo Alto and Singapore. | Finance |
GenEdit, Inc.
GenEdit, Inc. Pharmaceuticals: MajorHealth Technology GenEdit, Inc. develops gene therapies and gene editing-based therapeutics. Its proprietary nanoparticles applies for the development of CRISPR-based therapeutics and gene therapy products for a range of genetic diseases. The company was founded by Kunwoo Lee, Niren Murthy, and Hyo Min Park in 2016 and is headquartered in Berkeley, CA. | Health Technology |
Neuroptika, Inc.
Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Jiwoong Chun
